NASDAQ : DNLI
Denali Therapeutics Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 19.32 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 3.09B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Denali Therapeutics Inc. (DNLI) reported revenue of 3.60M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 3.60M | 330.53M | 108.46M | 48.66M | ||
| Cost of Revenue | 400.81M | 418.78M | 396.44M | 423.88M | 358.73M | 265.35M |
| Gross Profit | -397.21M | -418.78M | -396.44M | -93.34M | -250.27M | -216.69M |
| Selling, General & Admin | 144.74M | 136.56M | 105.44M | 103.35M | 90.47M | 79.06M |
| Operating Expenses | 144.74M | 136.56M | 105.44M | 103.35M | 90.47M | 79.06M |
| Operating Income | -541.95M | -555.34M | -501.88M | -196.70M | -340.74M | -295.75M |
| Interest & Investment Income | 24.98M | 32.65M | 29.52M | 7.55M | 13.14M | 13.34M |
| EBT Excluding Unusual Items | -516.97M | -522.69M | -472.36M | -189.15M | -327.61M | -282.41M |
| Gain (Loss) on Sale of Investments | 6.37M | 10.25M | 35.12M | 43.95M | 1.64M | -8.75M |
| Gain (Loss) on Sale of Assets | 14.54M | |||||
| Pretax Income | -511.35M | -512.44M | -422.70M | -145.19M | -325.97M | -291.16M |
| Income Tax Expense | 102.00K | 102.00K | 68.00K | 30.00K | 21.00K | -575.00K |
| Net Income | -511.45M | -512.54M | -422.77M | -145.22M | -325.99M | -290.58M |
| Net Income to Common | -511.45M | -512.54M | -422.77M | -145.22M | -325.99M | -290.58M |
| Shares Outstanding (Basic) | 180.47M | 172.65M | 164.47M | 137.37M | 125.53M | 121.52M |
| Shares Outstanding (Diluted) | 180.47M | 172.65M | 164.47M | 137.37M | 125.53M | 121.52M |
| EPS (Basic) | -2.83 | -2.97 | -2.57 | -1.06 | -2.60 | -2.39 |
| EPS (Diluted) | -2.83 | -2.97 | -2.57 | -1.06 | -2.60 | -2.39 |
| Free Cash Flow | -437.46M | -422.10M | -363.61M | -370.93M | -262.55M | -219.89M |
| Free Cash Flow Per Share | -2.42 | -2.44 | -2.21 | -2.70 | -2.09 | -1.81 |
| Gross Margin | -28.24% | -230.74% | ||||
| Operating Margin | -15,037.38% | -59.51% | -314.16% | -607.78% | ||
| Profit Margin | -14,191.20% | -43.94% | -300.56% | -597.15% | ||
| Free Cash Flow Margin | -12,138.10% | -112.22% | -242.06% | -451.88% | ||
| EBITDA | -526.06M | -540.53M | -492.89M | -187.87M | -330.36M | -287.16M |
| EBITDA Margin | -56.84% | |||||
| D&A For EBITDA | 15.89M | 14.81M | 8.99M | 8.83M | 10.38M | 8.59M |
| EBIT | -541.95M | -555.34M | -501.88M | -196.70M | -340.74M | -295.75M |
| EBIT Margin | -59.51% | |||||
| Revenue as Reported | 3.60M | 330.53M | 108.46M | 48.66M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 201.53M | 205.33M | 174.96M | 127.11M | 218.04M | 293.48M |
| Short-Term Investments | 508.94M | 662.55M | 657.37M | 907.40M | 1.12B | 571.93M |
| Cash & Short-Term Investments | 710.47M | 867.88M | 832.33M | 1.03B | 1.34B | 865.41M |
| Accounts Receivable | 3.93M | 2.18M | 2.17M | 3.42M | 9.28M | |
| Other Receivables | 1.50M | 1.23M | ||||
| Receivables | 5.43M | 2.18M | 2.17M | 3.42M | 9.28M | 1.23M |
| Prepaid Expenses | 33.89M | 30.60M | 29.93M | 26.21M | 26.82M | 30.60M |
| Total Current Assets | 753.93M | 900.66M | 864.44M | 1.06B | 1.37B | 897.23M |
| Property, Plant & Equipment | 113.42M | 119.94M | 125.63M | 71.64M | 74.52M | 69.61M |
| Long-Term Investments | 244.53M | 113.32M | 374.37M | 425.45M | ||
| Other Long-Term Assets | 10.82M | 10.94M | 9.74M | 18.14M | 13.40M | 11.87M |
| Total Assets | 1.16B | 1.14B | 1.37B | 1.15B | 1.46B | 1.40B |
| Accounts Payable | 11.81M | 3.33M | 11.14M | 9.48M | 2.79M | 4.78M |
| Accrued Expenses | 48.12M | 64.37M | 64.91M | 61.24M | 59.37M | 47.71M |
| Current Portion of Leases | 10.18M | 9.55M | 12.03M | 7.26M | 7.32M | 5.45M |
| Current Unearned Revenue | 290.05M | 320.30M | ||||
| Other Current Liabilities | 19.98M | 21.10M | 14.13M | 4.39M | ||
| Total Current Liabilities | 90.08M | 98.35M | 102.21M | 77.98M | 363.92M | 378.25M |
| Long-Term Leases | 27.50M | 32.74M | 42.29M | 44.98M | 53.03M | 58.55M |
| Long-Term Unearned Revenue | 479.00K | 4.69M | ||||
| Other Long-Term Liabilities | 205.19M | 379.00K | 379.00K | |||
| Total Liabilities | 322.78M | 131.09M | 144.50M | 122.96M | 417.81M | 441.87M |
| Common Stock | 1.92M | 1.89M | 1.77M | 1.71M | 1.69M | 1.55M |
| Additional Paid-In Capital | 3.14B | 3.06B | 2.76B | 2.14B | 2.02B | 1.61B |
| Retained Earnings | -2.31B | -2.05B | -1.54B | -1.12B | -970.99M | -645.00M |
| Comprehensive Income & Other | -1.97M | 682.00K | 2.02M | 643.00K | -6.89M | -2.50M |
| Total Common Equity | 835.18M | 1.01B | 1.23B | 1.03B | 1.04B | 962.29M |
| Shareholders' Equity | 835.18M | 1.01B | 1.23B | 1.03B | 1.04B | 962.29M |
| Total Liabilities & Equity | 1.16B | 1.14B | 1.37B | 1.15B | 1.46B | 1.40B |
| Total Debt | 37.69M | 42.29M | 54.32M | 52.24M | 60.35M | 64.01M |
| Net Cash (Debt) | 902.32M | 923.91M | 1.14B | 982.27M | 1.28B | 1.23B |
| Net Cash Per Share | 5.00 | 5.35 | 6.92 | 7.15 | 10.16 | 10.10 |
| Filing Date Shares Outstanding | 159.85M | 158.59M | 145.22M | 139.16M | 136.68M | 122.83M |
| Total Common Shares Outstanding | 159.76M | 156.18M | 144.22M | 138.39M | 135.97M | 122.28M |
| Working Capital | 663.84M | 802.31M | 762.23M | 986.15M | 1.01B | 518.99M |
| Book Value Per Share | 5.23 | 6.49 | 8.53 | 7.45 | 7.67 | 7.87 |
| Tangible Book Value | 799.93M | 1.01B | 1.23B | 1.03B | 1.04B | 962.29M |
| Tangible Book Value Per Share | 5.01 | 6.49 | 8.53 | 7.45 | 7.67 | 7.87 |
| Machinery | 67.54M | 60.37M | 50.35M | 37.60M | 32.97M | |
| Leasehold Improvements | 47.76M | 46.91M | 41.24M | 43.70M | 35.23M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -511.45M | -512.54M | -422.77M | -145.22M | -325.99M | -290.58M |
| Depreciation & Amortization | 15.89M | 14.81M | 8.99M | 8.83M | 10.38M | 8.59M |
| Loss (Gain) From Sale of Assets | -14.54M | |||||
| Asset Writedown & Restructuring Costs | 7.90M | |||||
| Loss (Gain) From Sale of Investments | -6.37M | -10.25M | -35.12M | -43.95M | -1.64M | 8.75M |
| Stock-Based Compensation | 95.09M | 99.63M | 102.88M | 108.10M | 99.85M | 85.25M |
| Other Operating Activities | 1.12M | -4.40M | -4.07M | -3.72M | -3.29M | -2.98M |
| Change in Accounts Payable | -3.38M | -7.52M | 1.44M | 2.43M | 2.27M | 3.71M |
| Change in Unearned Revenue | -290.53M | -34.46M | -15.66M | |||
| Change in Other Net Operating Assets | -16.88M | 7.67M | 15.50M | -1.82M | 8.16M | -8.46M |
| Operating Cash Flow | -434.04M | -412.60M | -347.69M | -357.99M | -244.72M | -211.39M |
| Capital Expenditures | -3.42M | -9.50M | -15.91M | -12.94M | -17.83M | -8.50M |
| Investment in Securities | 101.20M | 264.78M | -72.84M | 262.25M | -123.55M | -13.13M |
| Investing Cash Flow | 68.98M | 255.28M | -88.76M | 249.31M | -141.39M | -21.63M |
| Long-Term Debt Repaid | -8.17M | -32.34M | ||||
| Net Debt Issued (Repaid) | -1.42M | -8.17M | -32.34M | |||
| Issuance of Common Stock | 955.12M | 925.71M | 517.12M | 17.82M | 311.73M | 19.35M |
| Other Financing Activities | -528.32M | -728.32M | -480.00K | -1.06M | ||
| Financing Cash Flow | 425.38M | 189.22M | 484.30M | 17.82M | 310.67M | 19.35M |
| Net Cash Flow | 60.32M | 31.90M | 47.85M | -90.86M | -75.43M | -213.67M |
| Free Cash Flow | -437.46M | -422.10M | -363.61M | -370.93M | -262.55M | -219.89M |
| Free Cash Flow Margin | -12,138.10% | -112.22% | -242.06% | -451.88% | ||
| Free Cash Flow Per Share | -2.42 | -2.44 | -2.21 | -2.70 | -2.09 | -1.81 |
| Levered Free Cash Flow | -268.53M | -244.19M | -200.74M | -298.35M | -141.03M | 200.41M |
| Unlevered Free Cash Flow | -268.53M | -244.19M | -200.74M | -298.35M | -141.03M | 200.41M |
| Cash Interest Paid | 720.00K | 720.00K | 302.00K | |||
| Cash Income Tax Paid | 46.00K | 46.00K | 3.00K | 47.00K | 210.00K | |
| Change in Working Capital | -28.32M | 149.00K | 16.94M | -289.93M | -24.03M | -20.41M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 3.03B | 2.58B | 2.93B | 2.97B | 3.78B | 5.45B |
| Enterprise Value | 2.13B | 1.75B | 1.70B | 1.90B | 2.73B | 4.15B |
| Last Close Price | 18.94 | 16.51 | 20.38 | 21.46 | 27.81 | 44.60 |
| Forward PE | 46.46 | 46.46 | 46.46 | 46.46 | 46.46 | |
| PS Ratio | 840.04 | 8.97 | 34.82 | 111.93 | ||
| PB Ratio | 3.62 | 2.54 | 2.38 | 2.88 | 3.62 | 5.66 |
| P/TBV Ratio | 3.78 | 2.54 | 2.38 | 2.88 | 3.62 | 5.66 |
| EV/Sales Ratio | 589.68 | 5.76 | 25.20 | 85.35 | ||
| Debt / Equity Ratio | 0.04 | 0.04 | 0.04 | 0.05 | 0.06 | 0.07 |
| Net Debt / Equity Ratio | -1.08 | -0.91 | -0.93 | -0.95 | -1.22 | -1.27 |
| Net Debt / EBITDA Ratio | 1.72 | 1.71 | 2.31 | 5.23 | 3.86 | 4.27 |
| Net Debt / FCF Ratio | 2.06 | 2.19 | 3.13 | 2.65 | 4.86 | 5.58 |
| Asset Turnover | 0.00 | 0.25 | 0.08 | 0.03 | ||
| Quick Ratio | 7.95 | 8.85 | 8.16 | 13.31 | 3.70 | 2.29 |
| Current Ratio | 8.37 | 9.16 | 8.46 | 13.65 | 3.77 | 2.37 |
| Return on Equity (ROE) | -54.93% | -45.69% | -37.40% | -14.01% | -32.52% | -27.51% |
| Return on Assets (ROA) | -29.15% | -27.56% | -24.82% | -9.40% | -14.87% | -12.29% |
| Return on Invested Capital (ROIC) | -333.73% | -173.59% | -111.12% | -183.82% | ||
| Return on Capital Employed (ROCE) | -50.80% | -53.10% | -39.50% | -18.30% | -31.10% | -28.80% |
| Earnings Yield | -14.96% | -19.88% | -14.41% | -4.90% | -8.63% | -5.33% |
| FCF Yield | -14.45% | -16.37% | -12.40% | -12.51% | -6.95% | -4.04% |
| Buyback Yield / Dilution | -5.80% | -4.97% | -19.73% | -9.43% | -3.30% | -7.83% |